Viewing Study NCT00095693


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2026-01-09 @ 9:43 AM
Study NCT ID: NCT00095693
Status: TERMINATED
Last Update Posted: 2014-01-16
First Post: 2004-11-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-10
Start Date Type: None
Primary Completion Date: 2005-08
Primary Completion Date Type: ACTUAL
Completion Date: 2011-12
Completion Date Type: ACTUAL
First Submit Date: 2004-11-05
First Submit QC Date: None
Study First Post Date: 2004-11-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-01-15
Last Update Post Date: 2014-01-16
Last Update Post Date Type: ESTIMATED